15 insiders reported 54 Form 4 transactions for REGENXBIO Inc. (RGNX) over the past 18 months (most recent 2026-07-06). Recent activity: Simpson Curran (Chief Executive Officer) Buy 951 shares, PAKOLA STEVE (Chief Medical Officer) Buy 2,161 shares, Simpson Curran (Chief Executive Officer) Buy 1,453 shares, PAKOLA STEVE (Chief Medical Officer) Sell 2,161 shares, Simpson Curran (Chief Executive Officer) Sell 6,818 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | Simpson Curran | Chief Executive Officer | Buy | 951 | $6,653 |
| 2026-07-06 | PAKOLA STEVE | Chief Medical Officer | Buy | 2,161 | $16,985 |
| 2026-07-06 | Simpson Curran | Chief Executive Officer | Buy | 1,453 | $14,792 |
| 2026-07-06 | PAKOLA STEVE | Chief Medical Officer | Sell | 2,161 | $29,476 |
| 2026-07-06 | Simpson Curran | Chief Executive Officer | Sell | 6,818 | $89,248 |
| 2026-07-01 | PAKOLA STEVE | Chief Medical Officer | Sell | 19,608 | $216,472 |
| 2026-07-01 | PAKOLA STEVE | Chief Medical Officer | Buy | 36,725 | $288,658 |
| 2026-07-01 | PAKOLA STEVE | Chief Medical Officer | Sell | 36,725 | $472,284 |
| 2026-06-02 | Mills Kenneth T. | Director | Buy | 9,807 | $0 |
| 2026-06-02 | MIGAUSKY GEORGE V | Director | Buy | 9,807 | $0 |
| 2026-06-02 | STUMP DAVID C | Director | Buy | 9,807 | $0 |
| 2026-06-02 | Tasse Daniel | Director | Buy | 9,807 | $0 |
| 2026-06-02 | Fox Allan M. | Director | Buy | 9,807 | $0 |
| 2026-06-02 | Glucksmann Alexandra | Director | Buy | 9,807 | $0 |
| 2026-06-02 | Zachary Jennifer | Director | Buy | 9,807 | $0 |
| 2026-06-02 | Bennett Jean | Director | Buy | 9,807 | $0 |
| 2026-06-02 | KARABELAS ARGERIS N | Director | Buy | 9,807 | $0 |
| 2026-05-13 | PAKOLA STEVE | Chief Medical Officer | Sell | 15,309 | $168,705 |
| 2026-03-12 | PAKOLA STEVE | Chief Medical Officer | Sell | 5,124 | $53,033 |
| 2026-02-03 | PAKOLA STEVE | Chief Medical Officer | Sell | 5,267 | $58,780 |
| 2026-02-03 | Christmas Patrick J. | Chief Strategy & Legal Officer | Sell | 4,700 | $52,452 |
| 2026-01-29 | Mills Kenneth T. | Director | Buy | 225,000 | $2.9M |
| 2026-01-29 | Mills Kenneth T. | Director | Sell | 221,753 | $3.0M |
| 2026-01-08 | Christmas Patrick J. | Chief Strategy & Legal Officer | Buy | 73,749 | $0 |
| 2026-01-08 | Chan Mitchell | Chief Financial Officer | Buy | 73,749 | $0 |
Source: SEC Form 4 filings · as of 2026-07-06